eSignature programs in life sciences have to do more than move documents faster
They must prove signer identity, preserve record integrity, protect sensitive data, and stay defensible under 21 CFR Part 11, eIDAS, privacy, and internal quality requirements.
AI-enabled eSignature capabilities can improve workflow efficiency, user experience, and exception detection. But in regulated environments, speed only matters when the controls still hold: authentication, authorization, encryption, audit trails, metadata integrity, validation, monitoring, and vendor oversight.
This USDM white paper helps IT, Quality, Regulatory, and compliance leaders evaluate eSignature solutions through a security and data-integrity lens so digital signing can scale without weakening trust in the record.
What's inside
- Strengthen identity assurance: evaluate authentication, verification, and AI-assisted fraud detection without bypassing required controls.
- Protect signed records: align encryption, secure storage, metadata, and audit trails to preserve confidentiality and integrity.
- Meet regulatory expectations: map controls to 21 CFR Part 11 and eIDAS while maintaining the validity and trustworthiness of digital transactions.
- Govern AI-enabled personalization: improve accessibility and user experience while maintaining validation and privacy boundaries.
- Assess vendor readiness: use compliance, monitoring, and risk-based review practices to keep eSignature systems inspection-ready.
Why eSignature security is a regulated operating issue
Electronic signatures are often treated as a convenience feature. In life sciences, they are part of the regulated record. A weak eSignature process can create questions about who signed, what they approved, whether the record changed, and whether the system remained in a validated state.
AI can help teams detect suspicious behavior, tailor signing experiences, and reduce errors. It cannot become a shortcut around access control, encryption, auditability, or human accountability. Keeping these systems in a validated state aligns directly with a risk-based computer software assurance (CSA) approach.
KPIs to measure eSignature control maturity
Useful eSignature metrics should show whether the process is faster, safer, and easier to defend. Track control performance alongside cycle time so workflow gains do not hide compliance gaps.
What the white paper covers
- Security and data-integrity features: encryption, secure storage, signed-document protection, and metadata controls.
- Regulatory expectations: 21 CFR Part 11, eIDAS, and the need to maintain validity and trustworthiness of digital transactions.
- AI-enabled user experience: adaptive interfaces, accessibility, language support, and personalization considerations.
- Risk mitigation practices: regulatory compliance, assessments, continuous monitoring, and preemptive analysis to reduce misunderstandings or disputes.
Because most eSignature platforms are third-party SaaS, sustaining these controls over time is also a vendor-oversight problem — see how USDM applies third-party risk management and keeps validated cloud applications continuously compliant through USDM Cloud Assurance.
Who should download it
- IT leaders responsible for regulated eSignature platforms and identity controls.
- Quality and validation teams managing electronic records, audit trails, and change control.
- Regulatory and compliance leaders evaluating 21 CFR Part 11, eIDAS, privacy, and vendor risk.
- Business process owners who need faster signing workflows without sacrificing defensibility.
FAQ: eSignature security and data integrity in life sciences
What makes eSignature security a regulated issue and not just an IT preference?
In life sciences, an electronic signature is part of the regulated record. A weak signing process raises questions about who signed, what they approved, whether the record changed afterward, and whether the system stayed in a validated state — all of which must be answerable during an inspection under 21 CFR Part 11 and eIDAS.
What security and data-integrity controls should an eSignature solution provide?
The white paper looks at encryption, secure storage, signed-document protection, and metadata controls, supported by authentication, authorization, complete audit trails, validation, and continuous monitoring so confidentiality and integrity are preserved across the record's lifecycle.
Can AI safely improve eSignature workflows?
Yes, within boundaries. AI can help detect suspicious behavior, personalize and improve accessibility of signing experiences, and reduce errors. It cannot become a shortcut around access control, encryption, auditability, or human accountability, and AI-enabled changes still need validation before production use.
How do you keep a third-party eSignature platform inspection-ready over time?
Treat vendor oversight as an ongoing control: risk-based vendor assessment, compliance and monitoring practices, and change-impact review whenever the AI, workflow, vendor, or configuration changes. USDM pairs this with continuous compliance so updates don't silently break the validated state.
Which standards anchor eSignature compliance?
The paper centers on 21 CFR Part 11 and eIDAS, alongside privacy requirements and internal quality expectations, to maintain the validity and trustworthiness of digital transactions.
Download the white paper
Get the full USDM guide to enhancing security and ensuring data integrity in eSignature solutions — and evaluate your signing platform through a security and data-integrity lens. Have a specific eSignature, identity, or 21 CFR Part 11 challenge? Talk to a USDM compliance expert.